Form D · Pharmaceuticals
Primus Therapeutics Inc.
Skillman, NJ · CIK 0001501467
Offering snapshot reported Feb 16, 2011 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 12, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 16, 2011 | Initial | $500,000 | No comparison | 4 | SEC filing |
| Feb 16, 2011 | Initial | $300,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-155454
Source: Form D, filed Feb 16, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Falsetti | Director |
| Robert Hariri | Director |
| Mark Massad | Executive |
| Dennis O'donnell | Director, Executive |
| Andrew Sadosky | Director |
| Kenneth Taylor | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
23 Orchard Road Suite 105
Skillman, NJ, 08558
Skillman, NJ, 08558